Hepatitis B virus-induced hepatocellular carcinoma: Functional roles of MICA variants

Journal of Viral Hepatitis

Volumn 20, Issue 10, 2013, Pages 687-698

  Tong, H V ^a   Toan, N L ^b   Song, L H ^c   Bock, C T ^d   Kremsner, P G ^a   Velavan, T P ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b VIETNAM MILITARY MEDICAL UNIVERSITY   (Viet Nam)

^c Tran Hung Dao Hospital   (Viet Nam)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

hepatitis B virus; hepatocellular carcinoma; MICA; single nucleotide polymorphism; triplet repeat microsatellite

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; BIOLOGICAL MARKER; LIVER ENZYME; NATURAL KILLER CELL RECEPTOR NKG2D;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELLULAR IMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LIVER CELL CARCINOMA; LIVER INJURY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX I CHAIN RELATED GENE A; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; VIET NAM;

HEPATITIS B VIRUS; HEPATOCELLULAR CARCINOMA; MICA; SINGLE NUCLEOTIDE POLYMORPHISM; TRIPLET REPEAT MICROSATELLITE;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HEPATITIS B VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; VIETNAM; YOUNG ADULT;

EID: 84884128053     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12089     Document Type: Article

References (44)

1. Lavanchy D,. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11 (2): 97-107.
2. Di Bisceglie AM,. Hepatitis B and hepatocellular carcinoma. Hepatology 2009; 49 (5): S56-S60.
3. El-Serag HB,. Hepatocellular carcinoma. N Engl J Med 2011; 365 (12): 1118-1127.
4. Llovet JM, Burroughs A, Bruix J,. Hepatocellular carcinoma. Lancet 2003; 362 (9399): 1907-1917.
5. Nguyen VT, Law MG, Dore GJ,. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat 2009; 16 (7): 453-463.
6. Sung WK, Zheng H, Li S, et al,. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 2012; 44 (7): 765-769.
7. Blum HE, Moradpour D,. Viral pathogenesis of hepatocellular carcinoma. J Gastroenterol Hepatol 2002; 17 (Suppl. 3): S413-S420.
8. Chemin I, Zoulim F,. Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett 2009; 286 (1): 52-59.
9. Hu L, Zhai X, Liu J, et al,. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 2012; 55 (5): 1426-1431.
10. Miki D, Ochi H, Hayes CN, et al,. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat Genet 2011; 43 (8): 797-800.
11. Tanabe KK, Lemoine A, Finkelstein DM, et al,. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA 2008; 299 (1): 53-60.
12. Zhang H, Zhai Y, Hu Z, et al,. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 2010; 42 (9): 755-758.
13. Choy MK, Phipps ME,. MICA polymorphism: biology and importance in immunity and disease. Trends Mol Med 2010; 16 (3): 97-106.
14. Bauer S, Groh V, Wu J, et al,. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285 (5428): 727-729.
15. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T,. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001; 2 (3): 255-260.
16. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T,. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci USA 2003; 100 (16): 9452-9457.
17. Fisicaro P, Valdatta C, Boni C, et al,. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 2009; 58 (7): 974-982.
18. Dunn C, Brunetto M, Reynolds G, et al,. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007; 204 (3): 667-680.
19. Chuang WL, Liu HW, Chang WY,. Natural-Killer-Cell Activity in Patients with Hepatocellular-Carcinoma Relative to Early Development and Tumor Invasion. Cancer 1990; 65 (4): 926-930.
20. Kawarabayashi N, Seki S, Hatsuse K, et al,. Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000; 32 (5): 962-969.
21. Taketomi A, Shimada M, Shirabe K, Kajiyama K, Gion T, Sugimachi K,. Natural killer cell activity in patients with hepatocellular carcinoma-A new prognostic indicator after hepatectomy. Cancer 1998; 83 (1): 58-63.
22. Tosh K, Ravikumar M, Bell JT, Meisner S, Hill AV, Pitchappan R,. Variation in MICA and MICB genes and enhanced susceptibility to paucibacillary leprosy in South India. Hum Mol Genet 2006; 15 (19): 2880-2887.
23. Steinle A, Li P, Morris DL, et al,. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 2001; 53 (4): 279-287.
24. Mizuki N, Ota M, Kimura M, et al,. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci USA 1997; 94 (4): 1298-1303.
25. Kumar V, Kato N, Urabe Y, et al,. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet 2011; 43 (5): 455-458.
26. Jinushi M, Takehara T, Tatsumi T, et al,. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer 2003; 104 (3): 354-361.
27. Kohga K, Takehara T, Tatsumi T, et al,. Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma. Cancer Sci 2008; 99 (8): 1643-1649.
28. Hoang TV, Toan NL, Song LH, et al,. Ficolin-2 levels and FCN2 haplotypes influence hepatitis B infection outcome in Vietnamese patients. PLoS One 2011; 6 (11): e28113.
29. Song LH, Binh VQ, Duy DN, et al,. Mannose-binding lectin gene polymorphisms and hepatitis B virus infection in Vietnamese patients. Mutat Res 2003; 522 (1-2): 119-125.
30. Viny AD, Clemente MJ, Jasek M, et al,. MICA polymorphism identified by whole genome array associated with NKG2D-mediated cytotoxicity in T-cell large granular lymphocyte leukemia. Haematologica 2010; 95 (10): 1713-1721.
31. Tamaki S, Kawakami M, Yamanaka Y, et al,. Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma. Clin Immunol 2009; 130 (3): 331-337.
32. Clarke GM, Anderson CA, Pettersson FH, Cardon LR, Morris AP, Zondervan KT,. Basic statistical analysis in genetic case-control studies. Nat Protoc 2011; 6 (2): 121-133.
33. Tong HV, Toan NL, Song LH, Kremsner PG, Kun JF, Tp V,. Association of CISH -292A/T genetic variant with hepatitis B virus infection. Immunogenetics 2012; 64 (4): 261-265.
34. Hoshida Y, Fuchs BC, Tanabe KK,. Genomic risk of hepatitis C-related hepatocellular carcinoma. J Hepatol 2012; 56 (3): 729-730.
35. Yuasa H, Oike Y, Iwama A, et al,. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. EMBO J 2005; 24 (11): 1976-1987.
36. Karacki PS, Gao X, Thio CL, et al,. MICA and recovery from hepatitis C virus and hepatitis B virus infections. Genes Immun 2004; 5 (4): 261-266.
37. Oliviero B, Varchetta S, Paudice E, et al,. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009; 137 (3): 1151-1160, 1160.
38. Kumar V, Yi Lo PH, Sawai H, et al,. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma. PLoS One 2012; 7 (9): e44743.
39. Jinushi M, Takehara T, Tatsumi T, et al,. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol 2005; 43 (6): 1013-1020.
40. Groh V, Wu J, Yee C, Spies T,. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002; 419 (6908): 734-738.
41. Vilarinho S, Ogasawara K, Nishimura S, Lanier LL, Baron JL,. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci USA 2007; 104 (46): 18187-18192.
42. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T,. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996; 93 (22): 12445-12450.
43. Chen Y, Cheng M, Tian Z,. Hepatitis B virus down-regulates expressions of MHC class I molecules on hepatoplastoma cell line. Cell Mol Immunol 2006; 3 (5): 373-378.
44. Salih HR, Rammensee HG, Steinle A,. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 2002; 169 (8): 4098-4102.